Showing results (41-50 of 1,381) with videos related to
Sort By:
Pageof 139
Therapeutic Drug Monitoring|January 1, 1989
Clinical pharmacology of continuous infusion doxorubicinT W Sweatman, J J Lokich, M IsraelAnnals of Internal Medicine|December 1, 1978
Sequential carcinoembryonic antigen levels in the therapy of metastatic breast cancer: a predictor and monitor of response and relapseJ J Lokich, N Zamcheck, M W LowensteinJournal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1980
The effect of cancer chemotherapeutic agents on the liver-spleen scanW D Kaplan, D E Drum, J J LokichCancer|July 15, 1996
Comparison of costs for infusion versus bolus chemotherapy administration: analysis of five standard chemotherapy regimens in three common tumors--Part one. Model projections for cost based on chargesJ J Lokich, C L Moore, N R AndersonOncology|January 1, 1975
Combined 5-fluorouracil and hydroxyurea therapy for gastrointestinal cancerJ J Lokich, S W Pitman, A T SkarinJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1985
A pilot study of protracted venous infusion of 5-fluorouracil and concomitant radiation therapyT A Rich, J J Lokich, J T ChaffeyCancer|July 15, 1996
Comparison of costs for infusion versus bolus chemotherapy administration--Part two. Use of charges versus reimbursement for cost basisJ J Lokich, C L Moore, N R AndersonCancer Treatment Reports|September 1, 1983
Phase I study of continuous venous infusion of floxuridine (5-FUDR) chemotherapyJ J Lokich, H Sonneborn, S Paul, et al.Cancer|August 1, 1976
New multiple-agent chemotherapy (B-DOPA) for advanced Hodgkin's diseaseJ J Lokich, E Frei, N Jaffe, et al.Cancer Treatment Reports|September 1, 1982
Studies of Baker's antifol, methotrexate, and razoxane in advanced gastric cancer: A Gastrointestinal Tumor Study Group ReportH W Bruckner, J J Lokich, D M StableinPageof 139